A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Clinical trial NCT07569081 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07569081
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-05
- Primary completion
- 2028-12-06
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.